AzTrials
AzTrials

Disruptive BehaviorNCT03499600

Improving Satisfaction, Engagement and Outcomes Among Traditionally Underserved Children Through Cultural Formulation

A study testing Clinical Assessment and CFI and Clinical Assessment in people with Disruptive Behavior, run by Florida International University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The project at the center of this proposal will leverage a pilot randomized design to examine initial feasibility and preliminary effects of augmenting usual mental health evaluation procedures with a structured person-centered assessment tool that specifically considers the cultural context of patient mental health… Read more about this study

Who is it for?
Ages 2 to 7 years
Conditions the study is for
Disruptive Behavior
What is being tested?
Clinical Assessment and CFI and Clinical Assessment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
89 participants
Where
1 siteUnited States
Study dates
1 Aug 2017to 30 May 2019
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 7 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Child with elevated behavior problems
  • Child is between ages 2-7 years (inclusive)
  • Family seeking services at one of the University of Miami PCIT-Community Connect Centers

Who cannot join

  • Parent is actively abusing illegal substances
  • Child is younger than 2 years of age
  • Child is older than 7 years of age

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Miami Mailman Center

    Miami, Florida, 33137

Other trials in United States

About this study

Official title: Improving Satisfaction, Engagement and Clinical Outcomes Among Traditionally Underserved Children Through Cultural Formulation

The project at the center of this proposal will leverage a pilot randomized design to examine initial feasibility and preliminary effects of augmenting usual mental health evaluation procedures with a structured person-centered assessment tool that specifically considers the cultural context of patient mental health problems (i.e., the Cultural Formulation Interview; CFI) on parent satisfaction, engagement and clinical child outcomes in the treatment of early child behavior problems. Additional analyses will explore whether traditional barriers (e.g., stigma, ethnic identity, and daily stress) moderate the effects of the CFI on satisfaction, engagement and treatment outcomes.

Read the detailed description

This project is leveraging a pilot randomized design to evaluate initial feasibility and preliminarily examine whether augmenting assessment procedures for child behavior problems with the CFI improves satisfaction with assessment procedures and treatment, parent engagement in subsequent behavior parent training, and ultimately clinical child outcomes. Exploratory analyses will further consider whether traditional barriers to care moderate outcomes. The study is being conducted within a large South Florida mental health network serving predominately low-income minority families obtaining parent training for early child behavior problems. Participating families will be randomized at baseline to receive either the standard diagnostic and clinical assessment (CA) or CA+CFI.

Specifically, the investigators are interested in assessing study feasibility. Feasibility of recruitment and randomization, study retention, and condition integrity will be monitored. Additionally, clinician reports of CFI feasibility, acceptability and clinical utility will be examined. An additional main outcome will be initial satisfaction directly after the interview. It is hypothesized that families in the CA+CFI group will report higher levels of initial satisfaction than the CA group. A secondary goal is to assess preliminary effects of administering the CFI on treatment satisfaction, engagement and clinical child outcomes. Parents and therapists will report on their satisfaction with treatment. Engagement outcomes will be measured via: (a) initial session attendance, (b) drop out rate (c) session attendance rate, (d) homework completion rate, and (e) therapeutic alliance. Clinical outcomes will be measured via parent ratings of child behavior problems and parent time to skill mastery. It is hypothesized that CA+CFI families will demonstrate improved satisfaction, engagement and clinical outcomes relative to CA families. Further exploratory analyses will examine individual differences in effects related to traditional barriers to care. Exploratory analyses will examine stigma, ethnic identity, and daily stress as moderators of the effects of CFI administration on satisfaction, engagement and clinical outcomes. It is hypothesized that CFI effects will be particularly strong for families who experience greater traditional barriers to care.

Being tested
Clinical Assessment and CFI, Clinical Assessment
Keywords
Cultural assessment, Engagement, Diverse Populations
Medical subject headings
Problem Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Clinical Assessment and CFIBehavioural

    CA and CFI families will participate in the Cultural Formulation Interview prior to their standard intake.

  • Clinical AssessmentBehavioural

    CA families will participate their standard intake procedures.

Study groups in NCT03499600
Study groupRoleWhat they receive
Clinical Assessment and CFIExperimentalCA and CFI families will receive the Cultural Formulation Interview prior to their standard Clinical Assessment during their intake.
Receives: Behavioral: Clinical Assessment and CFI
Clinical Assessment OnlyActive comparatorCA families will receive a standard Clinical Assessment during intake.
Receives: Behavioral: Clinical Assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. CFI Clinician Questionnaire

    The CFI Clinician Questionnaire is a 4-item measure developed designed to assess clinical utility of the CFI. Items are rated on a 5-point Likert style scale ranging from 1='not at all' to 5='very much'. Each item has a minimum score of 1 and a max of 5. Items include the extent to which conducting the CFI influences content and quality of information obtained in the intake, realtionship with the caregiver, treatment planning, and differential diagnosis. Higher scores indicate higher levels of clinical utility of the CFI. The measure was given only to the CA + CFI condition.

    This analysis was utilized to assess for initial utility of the CFI and was mistakenly entered into the system as a primary outcome variable. This measure is not used to determine the effect of an experimental variable on participants in the study. Statistical analyses for this measure were descriptive and only examined for the experimental group.

    Measured: Post Intake Assessment (Week 0)

  2. Satisfaction With Intake Questionnaire

    The Satisfaction with Intake Questionnaire is a 7-item measure developed for use in the current study to assess parent and clinician satisfaction with their intake assessment. This measure assesses how well the patient/clinician felt the clinician understood the family's problems, cultural background, how their culture may influence their problem, and how much the parent trusts the clinician. Items are rated on a 5-point Likert style scale ranging from 1='not at all' to 5='very much', with higher scores representing higher satisfaction. Each item has a minimum of 1 and maximum of 5. Items were not summed.

    Two items were analyzed separately for the main outcomes: linear regressions tested condition effects on caregiver and provider satisfaction, and the extent to which the provider understood the caregivers' values or what is important to them.

    Measured: Post Intake Assessment (Week 0)

  3. CFI Fidelity Instrument

    The CFI Fidelity Instrument assesses fidelity to the CFI (i.e. adherence and competence) in the CA+CFI group and potential cross-condition contamination in CA condition. Independent evaluators masked to condition, study design, and study hypotheses coded recordings of all assessments.

    This analysis was utilized to assess for feasibility of the pilot study and was mistakenly entered into the system as a primary outcome variable. This measure is not used to determine the effect of an experimental variable on participants in the study. Statistical analyses for this measure were only descriptive.

    Measured: Post Intake Assessment (Week 0)

Secondary outcomes (9)
  1. Working Alliance Inventory-Short Form Revised

    The WAI-Short Form Revised (WAI-SR; Hatcher \& Gillaspy, 2006) is a 12-item clinician- and patient-report measure of therapeutic alliance that assesses (a) agreement on the tasks of therapy, (b) agreement on the goals of therapy and (c) development of an affective bond. Items are rated on a 5-point Likert style scale ranging from 1='never' to 5='always'. Scores on each sub scale are summed to create a total score. Total scores range from 12-60 with higher scores representing higher therapeutic alliance.

    Measured: Post Treatment (Anticipated average: Week 14)

  2. Treatment Response

    Treatment response reflected traditional PCIT graduation criteria: caregiver skill acquisition as coded against specific criteria in both phases of treatment; and (b) child behavior problems dropped into the subclinical range.

    Families were classified as Treatment Responders in accordance with formal PCIT graduation criteria, that is: (a) caregivers demonstrated skill acquisition, as coded against specific criteria in both phases of treatment; and (b) child behavior problems dropped into the subclinical range - i.e., Eyberg Child Behavior Inventory (ECBI) falls below 114).

    Participants were coded as either treatment responders=1, or treatment non-responders=0.

    Measured: Change from Baseline (Week 0) through post treatment (anticipated average: Week 14)

  3. Engagement

    Engagement will be measured for each family via: (a) dichotomous coding of initial session attendance (yes=1, no=0), (b) dichotomous coding of whether they completed the first treatment module (yes=1, no=0), (c) attendance rate (number of sessions attended over number of weeks in treatment), and (d) mean weekly homework completion across treatment (Homework Compliance)

    Measured: Change from Baseline (Week 0) through post treatment

  4. Therapy Attitudes Inventory

    The Therapy Attitudes Inventory (TAI; Brestan et al., 2000) is a 10-item parent-report of satisfaction with treatment including change in child behavior problems and parenting skills on a likert style scale from 1="nothing"-5="very many useful techniques". Items are summed to create a total score. Minimum value is 10 and maximum value is 50. Higher scores represent higher satisfaction with treatment.

    Measured: Post Treatment (anticipated average: Week 14)

  5. Eyberg Child Behavior Inventory

    The Eyberg Child Behavior Inventory (ECBI; Eyberg \& Pincus, 1999) is a 36-item parent-report measure of disruptive behavior problems in children as young as 2 years that has shown strong psychometrics. The intensity score is summed to form a total score and ranges from 36 to 252 with higher numbers representing more severe behavior problems.

    The difference in ECBI score between baseline and treatment completion was measured.

    Measured: Change from Baseline (Week 0) through post treatment (anticipated average: Week 14)

  6. Everyday Stressors Index

    The Everyday Stressors Index (ESI Hall, 1983) is a 20-item measure that assesses daily stressors experienced by economically disadvantaged parents with young children. Items are rated on a Likert-style scale ranging from 1='not at bothered' to 4='bothered a great deal' with higher scores indicating higher levels of stress. The minimum value=20, and maximum value=80

    This is a single time point assessment and is therefore not an outcome variable. There was an error when registering in clinical trials.

    Measured: Post Intake Assessment (Week 0)

  7. Multigroup Ethnic Identity Measure- Revised

    The Multigroup Ethnic Identity Measure- Revised (MEIM-R; Phinney \& Ong, 2007) is a 6-item measure that assesses exploration of and commitment to one's ethnic group. Items are rated on a 5-point Likert-style scale from 1='strongly disagree' to 6='strongly agree', with higher scores indicating stronger ethnic identity.

    This is a single time point assessment and is therefore not an outcome variable. There was an error when registering in clinical trials.

    Measured: Post Intake Assessment (Week 0)

  8. Parental Attitudes Toward Psychological Services Inventory

    Two subscales of the Parental Attitudes Toward Psychological Services Inventory (PATPSI; Turner, 2012) will be administered: help seeking attitudes scale (8 items) and the stigmatization scale (8 items) comprising 16 items total. The PATPSI assesses caregivers' attitudes toward outpatient mental health services. Items are rated on a 5-point Likert-style scale from 0='strongly disagree' to 5='strongly agree'.

    Item responses are summed to form a stigma total scale (minimum value=0 and maximum value=40) and a help seeking total scale (minimum value=0 and maximum value=40) with higher scores representing more mental health related stigma and more positive attitudes toward mental health services.

    This is a single time point assessment and is therefore not an outcome variable. There was an error when registering in clinical trials.

    Measured: Post Intake Assessment (Week 0)

  9. Everyday Discrimination Scale

    The Everyday Discrimination Scale (EDS; Williams et al., 1997) is a 9-item measure that assesses aspects of interpersonal discrimination or unfair treatment in their day-to-day life. Items are rated on a Likert-style scale ranging from 0='never' to 5='almost every day', with higher scores indicating more experiences of discrimination. The minimum score is 0 and maximum score is 45. Scores were averaged to create a mean discrimination score which could range from 0 to 5.

    This is a single time point assessment and is therefore not an outcome variable. There was an error when registering in clinical trials.

    Measured: Post Intake Assessment (Week 0)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Apr 2018
  2. Study start1 Aug 2017
  3. Primary completion20 Oct 2018
  4. Study completion30 May 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized control trial in which participants are randomly assigned to either receive a diagnostic and clinical assessment plus the cultural formulation interview (CA and CFI) or the diagnostic and clinical assessment (CA).
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
89 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03499600
Sponsor's protocol ID
106618
Other IDs
R36MH116677-01
Status last verified
Apr 2023
First submitted
9 Apr 2018
Last updated
7 Apr 2023
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: We will use a controlled access approach, using a robust system to review requests and provide secure access to de-identified data

Publications

  • Aggarwal NK. Cultural formulations in child and adolescent psychiatry. J Am Acad Child Adolesc Psychiatry. 2010 Apr;49(4):306-9. No abstract available.

    PubMed 20410723
  • Aggarwal NK, Desilva R, Nicasio AV, Boiler M, Lewis-Fernandez R. Does the Cultural Formulation Interview for the fifth revision of the diagnostic and statistical manual of mental disorders (DSM-5) affect medical communication? A qualitative exploratory study from the New York site. Ethn Health. 2015;20(1):1-28. doi: 10.1080/13557858.2013.857762. Epub 2013 Nov 15.

    PubMed 25372242
  • Aggarwal NK, Glass A, Tirado A, Boiler M, Nicasio A, Alegria M, Wall M, Lewis-Fernandez R. The development of the DSM-5 Cultural Formulation Interview-Fidelity Instrument (CFI-FI): a pilot study. J Health Care Poor Underserved. 2014 Aug;25(3):1397-417. doi: 10.1353/hpu.2014.0132.

    PubMed 25130248
  • Aggarwal NK, Lam P, Castillo EG, Weiss MG, Diaz E, Alarcon RD, van Dijk R, Rohlof H, Ndetei DM, Scalco M, Aguilar-Gaxiola S, Bassiri K, Deshpande S, Groen S, Jadhav S, Kirmayer LJ, Paralikar V, Westermeyer J, Santos F, Vega-Dienstmaier J, Anez L, Boiler M, Nicasio AV, Lewis-Fernandez R. How Do Clinicians Prefer Cultural Competence Training? Findings from the DSM-5 Cultural Formulation Interview Field Trial. Acad Psychiatry. 2016 Aug;40(4):584-91. doi: 10.1007/s40596-015-0429-3. Epub 2015 Oct 8.

    PubMed 26449983
  • Aggarwal NK, Nicasio AV, DeSilva R, Boiler M, Lewis-Fernandez R. Barriers to implementing the DSM-5 cultural formulation interview: a qualitative study. Cult Med Psychiatry. 2013 Sep;37(3):505-33. doi: 10.1007/s11013-013-9325-z.

    PubMed 23836098
  • Akincigil A, Olfson M, Siegel M, Zurlo KA, Walkup JT, Crystal S. Racial and ethnic disparities in depression care in community-dwelling elderly in the United States. Am J Public Health. 2012 Feb;102(2):319-28. doi: 10.2105/AJPH.2011.300349. Epub 2011 Dec 15.

    PubMed 22390446
  • Alegría, M., Green, J. G., McLaughlin, K. A., & Loder, S. (2015). Disparities in child and adolescent mental health and mental health services in the US.

  • Alegria M, Vallas M, Pumariega AJ. Racial and ethnic disparities in pediatric mental health. Child Adolesc Psychiatr Clin N Am. 2010 Oct;19(4):759-74. doi: 10.1016/j.chc.2010.07.001.

    PubMed 21056345
  • American Psychiatric Association (2000). Diagnostic and statisticalmanual of mental disorders (4th ed., text rev.). Washington, DC: Author.

  • American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.

  • Barkley RA, Shelton TL, Crosswait C, Moorehouse M, Fletcher K, Barrett S, Jenkins L, Metevia L. Multi-method psycho-educational intervention for preschool children with disruptive behavior: preliminary results at post-treatment. J Child Psychol Psychiatry. 2000 Mar;41(3):319-32.

    PubMed 10784079
  • Blanco C, Patel SR, Liu L, Jiang H, Lewis-Fernandez R, Schmidt AB, Liebowitz MR, Olfson M. National trends in ethnic disparities in mental health care. Med Care. 2007 Nov;45(11):1012-9. doi: 10.1097/MLR.0b013e3180ca95d3.

    PubMed 18049340
  • Briggs-Gowan MJ, Carter AS, Skuban EM, Horwitz SM. Prevalence of social-emotional and behavioral problems in a community sample of 1- and 2-year-old children. J Am Acad Child Adolesc Psychiatry. 2001 Jul;40(7):811-9. doi: 10.1097/00004583-200107000-00016.

    PubMed 11437020
  • Burke JD, Waldman I, Lahey BB. Predictive validity of childhood oppositional defiant disorder and conduct disorder: implications for the DSM-V. J Abnorm Psychol. 2010 Nov;119(4):739-51. doi: 10.1037/a0019708.

    PubMed 20853919
  • Burnett-Zeigler I, Lee Y, Bohnert KM. Ethnic Identity, Acculturation, and 12-Month Psychiatric Service Utilization Among Black and Hispanic Adults in the U.S. J Behav Health Serv Res. 2018 Jan;45(1):13-30. doi: 10.1007/s11414-017-9557-8.

    PubMed 28492979

Questions about this trial

What is this clinical trial studying?

A study testing Clinical Assessment and CFI and Clinical Assessment in people with Disruptive Behavior, run by Florida International University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 7 Apr 2023). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

CFI Clinician Questionnaire (time frame: Post Intake Assessment (Week 0)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03499600, which also lists 78 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Apr 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in